Coherus Oncology, Inc.

CHRS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$103,352$216,893$82,411$125,987
Short-Term Investments$88,311$20,744$0$0
Receivables$250,496$119,639$62,436$122,334
Inventory$2,048$4,513$3,518$70,094
Other Curr. Assets$8,700$11,716$154,902$11,532
Total Curr. Assets$460,955$380,205$310,175$341,583
Property Plant & Equip (Net)$1,633$1,907$2,256$2,837
Goodwill$0$0$0$0
Intangibles$49,484$52,312$52,979$53,646
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,447$5,040$5,656$50,467
Total NC Assets$55,564$59,259$60,891$106,950
Other Assets$0$0$0$0
Total Assets$516,519$439,464$371,066$448,533
Liabilities
Payables$24,893$37,622$40,930$28,456
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,875$12,505$46,250$33,112
Total Curr. Liab.$373,787$265,119$255,042$282,981
LT Debt$36,957$36,867$265,350$264,927
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,102$1,102$1,102$1,102
Other NC Liab.$14,953$14,143$30,188$28,227
Total NC Liab.$54,958$54,518$299,494$297,542
Other Liabilities$0$0$0$0
Cap. Leases$3,737$4,162$4,577$4,977
Total Liabilities$428,745$319,637$554,536$580,523
Equity
Pref Stock$0$0$0$0
Common Stock$12$12$12$12
Retained Earnings-$1,345,326-$1,309,795-$1,607,562-$1,550,993
AOCI-$203-$275-$275-$275
Other Equity$0$0$0$0
Total Equity$87,774$119,827-$183,470-$131,990
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$516,519$439,464$371,066$448,533
Net Debt-$66,395-$180,026$182,939$138,940